These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 18154547

  • 1. beta-Lactams without a suicide inhibitor.
    Giamarellou H.
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():194-7. PubMed ID: 18154547
    [Abstract] [Full Text] [Related]

  • 2. Temocillin use in England: clinical and microbiological efficacies in infections caused by extended-spectrum and/or derepressed AmpC β-lactamase-producing Enterobacteriaceae.
    Balakrishnan I, Awad-El-Kariem FM, Aali A, Kumari P, Mulla R, Tan B, Brudney D, Ladenheim D, Ghazy A, Khan I, Virgincar N, Iyer S, Carryn S, Van de Velde S.
    J Antimicrob Chemother; 2011 Nov; 66(11):2628-31. PubMed ID: 21810837
    [Abstract] [Full Text] [Related]

  • 3. Breakpoints for extended-spectrum beta-lactamase-producing Enterobacteriacae: pharmacokinetic/pharmacodynamic considerations.
    MacGowan A.
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():166-8. PubMed ID: 18154541
    [Abstract] [Full Text] [Related]

  • 4. Reevaluation of Enterobacteriaceae MIC/disk diffusion zone diameter regression scattergrams for 9 beta-lactams: adjustments of breakpoints for strains producing extended spectrum beta-lactamases.
    Jones RN, Craig WA, Ambrose PG, Dudley MN, Pottumarthy S.
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):235-46. PubMed ID: 16105568
    [Abstract] [Full Text] [Related]

  • 5. Orthodox and unorthodox clavulanate combinations against extended-spectrum beta-lactamase producers.
    Livermore DM, Hope R, Mushtaq S, Warner M.
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():189-93. PubMed ID: 18154546
    [Abstract] [Full Text] [Related]

  • 6. Assessment of the clinical significance of production of extended-spectrum beta-lactamases (ESBL) by Enterobacteriaceae.
    Henshke-Bar-Meir R, Yinnon AM, Rudensky B, Attias D, Schlesinger Y, Raveh D.
    Infection; 2006 Apr; 34(2):66-74. PubMed ID: 16703295
    [Abstract] [Full Text] [Related]

  • 7. Antimicrobial susceptibility of clinical isolates of Enterobacteriaceae producing complex beta-lactamase patterns including extended-spectrum enzymes.
    Segatore B, Setacci D, Perilli M, Franchino L, Franceschini N, Agnifili A, Rossolini GM, Amicosante G.
    Int J Antimicrob Agents; 2004 May; 23(5):480-6. PubMed ID: 15120727
    [Abstract] [Full Text] [Related]

  • 8. The use of cefepime for treating AmpC β-lactamase-producing Enterobacteriaceae.
    Tamma PD, Girdwood SC, Gopaul R, Tekle T, Roberts AA, Harris AD, Cosgrove SE, Carroll KC.
    Clin Infect Dis; 2013 Sep; 57(6):781-8. PubMed ID: 23759352
    [Abstract] [Full Text] [Related]

  • 9. Extended-spectrum beta-lactamases.
    Turner PJ.
    Clin Infect Dis; 2005 Aug 15; 41 Suppl 4():S273-5. PubMed ID: 16032564
    [Abstract] [Full Text] [Related]

  • 10. Consequences of revised CLSI and EUCAST guidelines for antibiotic susceptibility patterns of ESBL- and AmpC β-lactamase-producing clinical Enterobacteriaceae isolates.
    Hombach M, Mouttet B, Bloemberg GV.
    J Antimicrob Chemother; 2013 Sep 15; 68(9):2092-8. PubMed ID: 23633681
    [Abstract] [Full Text] [Related]

  • 11. Extended-spectrum beta-lactamases: implications for the clinical laboratory and therapy.
    Harada S, Ishii Y, Yamaguchi K.
    Korean J Lab Med; 2008 Dec 15; 28(6):401-12. PubMed ID: 19127103
    [Abstract] [Full Text] [Related]

  • 12. Determining a clinical framework for use of cefepime and β-lactam/β-lactamase inhibitors in the treatment of infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae.
    Nguyen HM, Shier KL, Graber CJ.
    J Antimicrob Chemother; 2014 Apr 15; 69(4):871-80. PubMed ID: 24265230
    [Abstract] [Full Text] [Related]

  • 13. Ertapenem susceptibility of extended spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care centre in India.
    Behera B, Mathur P, Das A, Kapil A.
    Singapore Med J; 2009 Jun 15; 50(6):628-32. PubMed ID: 19551319
    [Abstract] [Full Text] [Related]

  • 14. Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide.
    Drieux L, Brossier F, Sougakoff W, Jarlier V.
    Clin Microbiol Infect; 2008 Jan 15; 14 Suppl 1():90-103. PubMed ID: 18154532
    [Abstract] [Full Text] [Related]

  • 15. Doripenem activity tested against a global collection of Enterobacteriaceae, including isolates resistant to other extended-spectrum agents.
    Mendes RE, Rhomberg PR, Bell JM, Turnidge JD, Sader HS.
    Diagn Microbiol Infect Dis; 2009 Apr 15; 63(4):415-25. PubMed ID: 19249175
    [Abstract] [Full Text] [Related]

  • 16. Prevalence of clinical strains resistant to various beta-lactams in a tertiary care hospital in India.
    Datta P, Thakur A, Mishra B, Gupta V.
    Jpn J Infect Dis; 2004 Aug 15; 57(4):146-9. PubMed ID: 15329445
    [Abstract] [Full Text] [Related]

  • 17. In vitro activity of fourth generation cephalosporins against enterobacteriaceae producing extended-spectrum beta-lactamases.
    Sanders CC.
    J Chemother; 1996 Feb 15; 8 Suppl 2():57-62. PubMed ID: 8738847
    [Abstract] [Full Text] [Related]

  • 18. A simple disc diffusion method for detecting AmpC and extended-spectrum beta-lactamases in clinical isolates of Enterobacteriaceae.
    Derbyshire H, Kay G, Evans K, Vaughan C, Kavuri U, Winstanley T.
    J Antimicrob Chemother; 2009 Mar 15; 63(3):497-501. PubMed ID: 19155228
    [Abstract] [Full Text] [Related]

  • 19. Breakpoints for intravenously used cephalosporins in Enterobacteriaceae--EUCAST and CLSI breakpoints.
    Kahlmeter G.
    Clin Microbiol Infect; 2008 Jan 15; 14 Suppl 1():169-74. PubMed ID: 18154542
    [Abstract] [Full Text] [Related]

  • 20. Prevalence and characterization of extended-spectrum beta-lactamase-producing Enterobacteriaceae isolated in Korean hospitals.
    Ko KS, Lee MY, Song JH, Lee H, Jung DS, Jung SI, Kim SW, Chang HH, Yeom JS, Kim YS, Ki HK, Chung DR, Kwon KT, Peck KR, Lee NY.
    Diagn Microbiol Infect Dis; 2008 Aug 15; 61(4):453-9. PubMed ID: 18482815
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.